Asian vaccine stocks followed their global peers lower, with Shanghai Fosun dropping by as much as 21% in Hong Kong, after Merck & Co. said its experimental antiviral pill cuts the risk of hospitalization and death from Covid-19 in half.
Asian vaccine stocks followed their global peers lower, with Shanghai Fosun dropping by as much as 21% in Hong Kong, after Merck & Co. said its experimental antiviral pill cuts the risk of hospitalization and death from Covid-19 in half.